Concurrent neoadjuvant chemotherapy is an independent risk factor of stroke, all-cause morbidity, and mortality in patients undergoing brain tumor resection

Nicholas B. Abt, Mohamad Bydon, Rafael De La Garza-Ramos, Kelly McGovern, Alessandro Olivi, Judy Huang, Ali Bydon

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Concurrent neoadjuvant chemotherapy is an independent risk factor of stroke, all-cause morbidity, and mortality in patients undergoing brain tumor resection'. Together they form a unique fingerprint.

Medicine & Life Sciences